| The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia (NCT00687388) | Samsung Medical Center | 2008-05-01 |
| A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia (NCT01387893) | Kaiser Permanente | 2008-05-01 |
| A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart (NCT00690950) | Urologic Consultants of Southeastern PA | 2008-05-01 |
| On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP) (NCT00564460) | University of Alberta | 2008-02-01 |
| PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate (NCT00527371) | St. Joseph's Healthcare Hamilton | 2008-01-01 |
| Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate (NCT00880672) | Seoul National University Hospital | 2008-01-01 |
| Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men (NCT00540124) | Eli Lilly and Company | 2007-10-01 |
| Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) (NCT00527605) | GlaxoSmithKline | 2007-10-01 |
| MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia (NCT00501371) | Health Ever Bio-Tech Co., Ltd. | 2007-07-01 |
| A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization (NCT00465101) | American Medical Systems | 2007-05-01 |
| Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter (NCT00421421) | GlaxoSmithKline | 2007-03-01 |
| Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia (NCT00730418) | Samsung Medical Center | 2007-01-01 |
| Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT00386009) | Eli Lilly and Company | 2006-10-01 |
| Botulinum Toxin Injection for the Management of BPH (NCT00451191) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2006-10-01 |
| A Clinical Trial Comparing Laser TURP With and Without Dutasteride. (NCT00431626) | Northwestern University | 2006-10-01 |
| Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT00384930) | Eli Lilly and Company | 2006-08-01 |
| Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction (NCT00827814) | Samsung Medical Center | 2006-06-01 |
| Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH (NCT00359905) | RECORDATI GROUP | 2006-05-01 |
| A Prospective Evaluation of the GreenLight Model 120 Laser (NCT00364585) | Weill Medical College of Cornell University | 2006-05-01 |
| One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients (NCT00472251) | Seoul National University Hospital | 2006-05-01 |
| Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH (NCT00347061) | Sanofi | 2006-05-01 |
| Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration (NCT00890851) | Assistance Publique - Hôpitaux de Paris | 2006-03-01 |
| Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) (NCT00274417) | Urology of Virginia | 2006-01-01 |
| Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia (NCT00284518) | Allergan | 2005-12-01 |
| Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia (NCT00657839) | Bayer | 2005-10-01 |
| A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. (NCT00379067) | Astellas Pharma Inc | 2005-10-01 |
| Study of the Effects of Pomegranate Tablets on Enlarged Prostates (NCT00381108) | University of California, Irvine | 2005-09-01 |
| Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma (NCT00400894) | ProteoSys AG | 2005-09-01 |
| The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months (NCT00224133) | Watson Pharmaceuticals | 2005-09-01 |
| Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia (NCT00701779) | Siami, Paul F., M.D. | 2005-09-01 |
| Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia (NCT00237536) | Threshold Pharmaceuticals | 2005-06-01 |
| Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia (NCT00435448) | Threshold Pharmaceuticals | 2005-06-01 |
| Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate (NCT00169767) | Indiana Kidney Stone Institute | 2005-05-01 |
| A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo (NCT00224120) | Watson Pharmaceuticals | 2005-05-01 |
| Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer (NCT00375765) | GlaxoSmithKline | 2005-04-01 |
| TRADE-Testosterone Replacement and Dutasteride Effectiveness (NCT00194675) | University of Washington | 2005-03-01 |
| AVODART(Dutasteride) Post-marketing Surveillance(PMS) (NCT01299571) | GlaxoSmithKline | 2004-12-01 |
| Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia (NCT00593593) | GlaxoSmithKline | 2004-12-01 |
| Kinetics of the Finasteride Prostate Induced Apoptosis (NCT00130767) | Hospices Civils de Lyon | 2004-12-01 |
| Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (NCT00409357) | Sanofi | 2004-11-01 |
| Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia (NCT00908427) | Samsung Medical Center | 2004-06-01 |
| Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker (NCT00680680) | Franklin D. Gaylis, MD Inc. | 2004-05-01 |
| Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) (NCT00199550) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2004-05-01 |
| Minimally Invasive Surgical Therapy for BPH (NCT00064649) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-04-01 |
| A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) (NCT00127179) | Organon and Co | 2004-01-01 |
| Laser Prostatectomy Database and Registry (NCT00159406) | Indiana Kidney Stone Institute | 2003-10-01 |
| Once Daily Given Alfuzosin in the Treatment of BPH (NCT00637715) | Sanofi | 2003-10-01 |
| Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia (NCT00969072) | GlaxoSmithKline | 2003-08-01 |
| Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia (NCT00077012) | QLT Inc. | 2003-03-01 |
| The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score (NCT00540891) | Sanofi | 2003-02-01 |
| A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin (NCT00645034) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| Questioning Patients About Adverse Medical Events (NCT00187616) | University of California, San Francisco | 2002-04-01 |
| Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) (NCT00037141) | American Medical Systems | 2002-03-01 |
| Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) (NCT01250483) | Seoul National University Hospital | 2001-01-01 |
| Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice (NCT00111592) | Maastricht University Medical Center | 2000-08-01 |
| Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate (NCT00468026) | ProstaPlant Urology System Ltd. | |
| Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia (NCT07715448) | Beni-Suef University | |
| To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate (NCT01958892) | Singapore General Hospital | |